Publication of a case report showing first promising clinical data on FG001s use in treatment of meningioma brain tumor

Copenhagen, Denmark, 9 November 2021. FluoGuide A/S ("FluoGuide" or the “Company”) is pleased to announce the publication of a clinical case report for FG001 in meningioma. The case report indicates that FG001 may be used in other types of brain tumors than High Grade Glioma and thereby opens new opportunities for the realization of clinical and commercial potential of FG001

The release as fetched from its publisher. fluoguide.com ↗